Law Firm Of Levi & Korsinsky, LLP Announces Class Action Against DGSE Companies Inc. (DGSE), Body Central Corp. (BODY) And Vertex Pharmaceuticals Inc. (VRTX) And Investigation Of Mediware Information Systems, Inc. (MEDW)
NEW YORK, Sept. 24, 2012 /PRNewswire/ --
DGSE Companies Inc.Levi & Korsinsky announces that a class action lawsuit has been commenced in the USDC for the Northern District of Texas on behalf of investors who purchased DGSE Companies Inc. (NYSE MKT: DGSE) stock between April 15, 2011 and April 17, 2012.
For more information, click here: http://zlk.9nl.com/dgse-companies-dgse . You have until November 6, 2012 to request that the Court appoint you as lead plaintiff.
Body Central Corporation Levi & Korsinsky announces that a class action lawsuit has been commenced in the S District Court for the Middle District of Florida on behalf of investors who purchased Body Central Corporation (NasdaqGS: BODY) securities between November 10, 2011 and June 18, 2012.
For more information, click here: http://zlk.9nl.com/body-central-body . You have until October 29, 2012 to request that the Court appoint you as lead plaintiff. Vertex Pharmaceuticals IncorporatedLevi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of investors who acquired Vertex Pharmaceuticals Incorporated (NasdaqGS: VRTX) securities between May 7, 2012 and June 27, 2012. For more information, click here: http://zlk.9nl.com/vertex-pharmaceuticals-vertex . You have until November 5, 2012 to request that the Court appoint you as lead plaintiff. Mediware Information Systems, Inc.Levi & Korsinsky is investigating the Board of Directors of Mediware Information Systems, Inc. (Nasdaq: MEDW) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Thoma Bravo, LLC. for $22.00 per share. Click here to learn more about the investigation: http://zlk.9nl.com/mediware-information-systems-medw , or call: 877-363-5972.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
